Stockreport

Context Therapeutics Reports Full Year 2023 Operating and Financial Results

Context Therapeutics Inc.  (CNTX) 
PDF CTIM-76 IND filing on track for late March 2024 Cash and cash equivalents of $14.4 million as of December 31, 2023 Company expects its cash and cash equivalents will c [Read more]